Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aptevo Therapeutics Inc (APVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptevo Therapeutics Inc 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 USA

P: 206-838-0500 F: 206-838-0503

Description:

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 38,777
Shares Outstanding, K 45,090
Annual Sales, $ 23,070 K
Annual Net Income, $ -53,690 K
Last Quarter Sales, $ 7,020 K
Last Quarter Net Income, $ -12,020 K
60-Month Beta 2.26
% of Insider Shareholders 11.74%
% of Institutional Shareholders 36.37%
Float, K 39,796
% Float 88.26%

Growth:

1-Year Return -82.55%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/08/19
Earnings Per Share ttm -1.58
EPS Growth vs. Prev Year 30.16%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

APVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.90
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -122.33
Return-on-Assets (Before Tax) -65.38
Profit Margin % -232.73
Net Margin % N/A
Debt/Equity 0.63
Price/Sales 1.68
Price/Cash Flow N/A
Price/Book 0.94
Book Value/Share 0.91
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar